Intelligence · Clinical Development
Pipeline search results
Programs matching “msc” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 43 pipeline programs matching "msc" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Debamestrocel - MSC-NTF (NurOwn)
BRAINSTORM CELL THERAPEUTICS INC.
Amyotrophic Lateral Sclerosis (ALS)
1 trial -
Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT)
Disc Medicine
Symptomatic articular cartilage lesion of the knee (femoral condyles or trochlea)
1 trial -
MC-MSC.1/aGvHD
Medac Gesellschaft fuer klinische Spezialpraeparate mbH
Steroid refractory Acute Graft versus host Disease
1 trial -
NurOwn® (MSC-NTF cells)
BRAINSTORM CELL THERAPEUTICS INC.
Amyotrophic Lateral Sclerosis (ALS)
2 trials -
2G-MSC-GVHD
The George Institute
Patients who have developed acute GVHD refractory to corticosteroids and ruxolitinib or that are not eligible to receive ruxolitinib
1 trial -
3D hypoxia-preconditioned UC-MSC group
The First People's Hospital of Lianyungang
Severe Aplastic Anemia (SAA)
1 trial -
ACT-20-MSC
Aspire Biopharma Holdings
COVID-19 Pneumonia
1 trial -
ADMSC-fib safety and efficacy in patients with chronico wounds
The George Institute
chronic wounds
1 trial -
Allogeneic MSC (AlloMSC)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Refractory Systemic Lupus Erythematosus
1 trial -
BM-MSCs
The First People's Hospital of Lianyungang
Kidney Transplantation
2 trials -
BMSC transplantation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Cirrhosis
1 trial -
Darleukin, Fibromun
Philogen S.p.A.
Patients with high-risk, locally advanced (non-metastatic, node negative, single or multifocal), Basal Cell Carcinoma (BCC) or cutaneous Squamous Cell Carcinoma (cSCC) amenable to intratumoral injection, not eligible to surgery or radiation therapy according to the evaluation of a local interdisciplinary tumor board or who refuse surgery or radiation therapy and for whom a histological evaluation is available according to international guidelines.
1 trial -
GARM-Autism Adults
Blackmores Limited
Autism Spectrum Disorder
1 trial -
HB-adMSC
United Therapeutics Europe Ltd
COVID-19
1 trial -
HUMSCs combined with bovine type I collagen
The First People's Hospital of Lianyungang
Burn Wounds
1 trial -
Human Umbilical Cord derived MSCs
CytoMed Therapeutics Ltd
Lupus Nephritis
1 trial -
Infusion of MSC
Lxo Ireland Designated Activity Company
Discordant Immunological Response in HIV Infected Subjects
1 trial -
Intravenous administration of 1 million of MSC
Lxo Ireland Designated Activity Company
Amyotrophic Lateral Sclerosis
1 trial -
MSC
Shandong University
Type 2 Diabetes
1 trial -
MSC
The Children's Hospital of Zhejiang University School of Medicine
BPD - Bronchopulmonary Dysplasia
1 trial -
MSC and PRP
Hospital Authority, Hong Kong
Type 1 Diabetes Mellitus
1 trial -
MSC-NTF cells transplantation (IM)
BRAINSTORM CELL THERAPEUTICS INC.
Amyotrophic Lateral Sclerosis
1 trial -
MSC-NTF-002-HMO-CTIL
BRAINSTORM CELL THERAPEUTICS INC.
Amyotrophic Lateral Sclerosis
1 trial -
Medical Collagen Membrane with MSC
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Wounds
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.